Cargando…
Maternal acetaminophen use and cognitive development at 4 years: the Ontario Birth Study
BACKGROUND: Studies have suggested a link between prenatal maternal acetaminophen use and adverse developmental outcomes in children. However, there exists a knowledge gap regarding overall cognitive development and use of acetaminophen, especially concerning the timing of use in pregnancy. This stu...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261144/ https://www.ncbi.nlm.nih.gov/pubmed/35794252 http://dx.doi.org/10.1038/s41390-022-02182-w |
_version_ | 1784742207956189184 |
---|---|
author | Lye, Jennifer M. Knight, Julia A. Arneja, Jasleen Seeto, Ryan A. Wong, Jody Adel khani, Nadya Brooks, Jennifer D. Levitan, Robert D. Matthews, Stephen G. Lye, Stephen J. Hung, Rayjean J. |
author_facet | Lye, Jennifer M. Knight, Julia A. Arneja, Jasleen Seeto, Ryan A. Wong, Jody Adel khani, Nadya Brooks, Jennifer D. Levitan, Robert D. Matthews, Stephen G. Lye, Stephen J. Hung, Rayjean J. |
author_sort | Lye, Jennifer M. |
collection | PubMed |
description | BACKGROUND: Studies have suggested a link between prenatal maternal acetaminophen use and adverse developmental outcomes in children. However, there exists a knowledge gap regarding overall cognitive development and use of acetaminophen, especially concerning the timing of use in pregnancy. This study aimed to characterize the relationship between maternal acetaminophen use and cognitive development at 4 years. METHODS: This analysis included data collected throughout pregnancy and delivery from women in the Ontario Birth Study prospective cohort from 2013 to 2019 and from the NIH Toolbox Early Childhood Cognition battery administered to 4-year-old children between 2018 and 2021 (n = 436). The exposure was maternal acetaminophen use and the primary outcome was a cognition composite score. The relationship between exposure and outcome was determined using Poisson regression with a robust error variance. RESULTS: We did not observe any association between maternal acetaminophen intake any time before or during pregnancy and low cognition composite score of offspring. The IRR of suboptimal overall cognition was 1.38 (0.78–2.45), 1.22 (0.67–2.22), 0.80 (0.44–1.47), and 1.56 (0.74–3.29) for maternal use of acetaminophen before, in early, late, or overall pregnancy, respectively. CONCLUSION: Current data do not provide evidence to support a relationship of maternal acetaminophen use during pregnancy with adverse cognitive effects at 4 years. IMPACT: Acetaminophen use during pregnancy may influence the risk of child neurocognitive disorders, but there is conflicting evidence of its relationship to sub-clinical measures of cognitive development such as executive function. The study design allowed us to examine the role of timing of acetaminophen use in its relationship with cognitive development, based on a validated and standardized tablet-administered instrument for children, instead of a teacher or parent report. We did not observe a clear relationship between maternal acetaminophen use at different timepoints during pregnancy and child cognitive development. |
format | Online Article Text |
id | pubmed-9261144 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group US |
record_format | MEDLINE/PubMed |
spelling | pubmed-92611442022-07-07 Maternal acetaminophen use and cognitive development at 4 years: the Ontario Birth Study Lye, Jennifer M. Knight, Julia A. Arneja, Jasleen Seeto, Ryan A. Wong, Jody Adel khani, Nadya Brooks, Jennifer D. Levitan, Robert D. Matthews, Stephen G. Lye, Stephen J. Hung, Rayjean J. Pediatr Res Clinical Research Article BACKGROUND: Studies have suggested a link between prenatal maternal acetaminophen use and adverse developmental outcomes in children. However, there exists a knowledge gap regarding overall cognitive development and use of acetaminophen, especially concerning the timing of use in pregnancy. This study aimed to characterize the relationship between maternal acetaminophen use and cognitive development at 4 years. METHODS: This analysis included data collected throughout pregnancy and delivery from women in the Ontario Birth Study prospective cohort from 2013 to 2019 and from the NIH Toolbox Early Childhood Cognition battery administered to 4-year-old children between 2018 and 2021 (n = 436). The exposure was maternal acetaminophen use and the primary outcome was a cognition composite score. The relationship between exposure and outcome was determined using Poisson regression with a robust error variance. RESULTS: We did not observe any association between maternal acetaminophen intake any time before or during pregnancy and low cognition composite score of offspring. The IRR of suboptimal overall cognition was 1.38 (0.78–2.45), 1.22 (0.67–2.22), 0.80 (0.44–1.47), and 1.56 (0.74–3.29) for maternal use of acetaminophen before, in early, late, or overall pregnancy, respectively. CONCLUSION: Current data do not provide evidence to support a relationship of maternal acetaminophen use during pregnancy with adverse cognitive effects at 4 years. IMPACT: Acetaminophen use during pregnancy may influence the risk of child neurocognitive disorders, but there is conflicting evidence of its relationship to sub-clinical measures of cognitive development such as executive function. The study design allowed us to examine the role of timing of acetaminophen use in its relationship with cognitive development, based on a validated and standardized tablet-administered instrument for children, instead of a teacher or parent report. We did not observe a clear relationship between maternal acetaminophen use at different timepoints during pregnancy and child cognitive development. Nature Publishing Group US 2022-07-07 2023 /pmc/articles/PMC9261144/ /pubmed/35794252 http://dx.doi.org/10.1038/s41390-022-02182-w Text en © The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Clinical Research Article Lye, Jennifer M. Knight, Julia A. Arneja, Jasleen Seeto, Ryan A. Wong, Jody Adel khani, Nadya Brooks, Jennifer D. Levitan, Robert D. Matthews, Stephen G. Lye, Stephen J. Hung, Rayjean J. Maternal acetaminophen use and cognitive development at 4 years: the Ontario Birth Study |
title | Maternal acetaminophen use and cognitive development at 4 years: the Ontario Birth Study |
title_full | Maternal acetaminophen use and cognitive development at 4 years: the Ontario Birth Study |
title_fullStr | Maternal acetaminophen use and cognitive development at 4 years: the Ontario Birth Study |
title_full_unstemmed | Maternal acetaminophen use and cognitive development at 4 years: the Ontario Birth Study |
title_short | Maternal acetaminophen use and cognitive development at 4 years: the Ontario Birth Study |
title_sort | maternal acetaminophen use and cognitive development at 4 years: the ontario birth study |
topic | Clinical Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261144/ https://www.ncbi.nlm.nih.gov/pubmed/35794252 http://dx.doi.org/10.1038/s41390-022-02182-w |
work_keys_str_mv | AT lyejenniferm maternalacetaminophenuseandcognitivedevelopmentat4yearstheontariobirthstudy AT knightjuliaa maternalacetaminophenuseandcognitivedevelopmentat4yearstheontariobirthstudy AT arnejajasleen maternalacetaminophenuseandcognitivedevelopmentat4yearstheontariobirthstudy AT seetoryana maternalacetaminophenuseandcognitivedevelopmentat4yearstheontariobirthstudy AT wongjody maternalacetaminophenuseandcognitivedevelopmentat4yearstheontariobirthstudy AT adelkhaninadya maternalacetaminophenuseandcognitivedevelopmentat4yearstheontariobirthstudy AT brooksjenniferd maternalacetaminophenuseandcognitivedevelopmentat4yearstheontariobirthstudy AT levitanrobertd maternalacetaminophenuseandcognitivedevelopmentat4yearstheontariobirthstudy AT matthewsstepheng maternalacetaminophenuseandcognitivedevelopmentat4yearstheontariobirthstudy AT lyestephenj maternalacetaminophenuseandcognitivedevelopmentat4yearstheontariobirthstudy AT hungrayjeanj maternalacetaminophenuseandcognitivedevelopmentat4yearstheontariobirthstudy |